BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.69
+0.06 (0.79%)
At close: Nov 6, 2026, 4:00 PM EST
7.71
+0.02 (0.26%)
After-hours: Nov 6, 2026, 7:30 PM EST
BioCryst Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -359.66 | 263.86 | -88.88 | -226.54 | -247.12 | -184.06 |
Depreciation & Amortization | 3.71 | 3.49 | 3.01 | 2.87 | 2.25 | 0.89 |
Other Amortization | -0.23 | - | - | - | - | - |
Loss (Gain) From Sale of Assets | -4.02 | -4.12 | - | - | - | - |
Asset Writedown & Restructuring Costs | 707.3 | - | - | 1.55 | - | - |
Loss (Gain) From Sale of Investments | -2.52 | -4.33 | -11.47 | -10.26 | -1.78 | -0 |
Loss (Gain) on Equity Investments | 17.55 | 17.55 | - | - | - | - |
Stock-Based Compensation | 68.76 | 85.07 | 65.41 | 55.62 | 44.7 | 34.64 |
Other Operating Activities | 43.56 | 42.75 | 67.19 | 114.03 | 99.03 | -1.75 |
Change in Accounts Receivable | -28.49 | -36.81 | -22.7 | -6.1 | -21.47 | -20.82 |
Change in Inventory | -16.58 | -1.64 | -4.16 | -1.45 | -12.42 | -8.77 |
Change in Accounts Payable | -10.31 | 57.8 | 14.78 | 12.53 | -22.36 | 39.41 |
Change in Unearned Revenue | 7.16 | - | - | -1.23 | -0.11 | 1.28 |
Change in Other Net Operating Assets | -58.73 | -76.26 | -75.2 | -36.16 | -2.58 | -2.99 |
Operating Cash Flow | 367.49 | 347.37 | -52.02 | -95.14 | -161.85 | -142.16 |
Operating Cash Flow Growth | 632.12% | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -1.65 | -2.47 | -1.12 | -2.17 | -1.35 | -2.39 |
Sale of Property, Plant & Equipment | 0.07 | 0.55 | - | - | - | - |
Divestitures | -6.18 | -6.18 | - | - | - | - |
Investment in Securities | -43.92 | -5.59 | 53.72 | -129.33 | -126.89 | 18.19 |
Investing Cash Flow | -541.16 | -13.69 | 52.59 | -131.5 | -128.24 | 15.8 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | 300 | 73.07 | 293.87 |
Long-Term Debt Repaid | - | -334.76 | -1.7 | -262.88 | - | - |
Net Debt Issued (Repaid) | 173.34 | -334.76 | -1.7 | 37.12 | 73.07 | 293.87 |
Issuance of Common Stock | 30.73 | 9.17 | 3.48 | 8.68 | 14.96 | 65.79 |
Repurchase of Common Stock | -12.26 | -8.85 | -7.54 | -2.17 | - | - |
Other Financing Activities | -20.45 | -15.5 | - | -11.15 | - | - |
Financing Cash Flow | 171.36 | -349.93 | -5.76 | 32.49 | 88.03 | 359.67 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.17 | 1.27 | -0.94 | 0.36 | 0.57 | 0.07 |
Net Cash Flow | 12.37 | -14.99 | -6.12 | -193.79 | -201.5 | 233.39 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 365.85 | 344.9 | -53.14 | -97.31 | -163.2 | -144.54 |
Free Cash Flow Growth | 664.49% | - | - | - | - | - |
Free Cash Flow Margin | 38.05% | 39.42% | -11.79% | -29.36% | -60.26% | -91.97% |
Free Cash Flow Per Share | 1.52 | 1.58 | -0.26 | -0.51 | -0.88 | -0.81 |
Levered Free Cash Flow | 301.09 | 256.42 | 11.95 | -67.23 | -141.51 | -122.67 |
Unlevered Free Cash Flow | 349.1 | 305.72 | 73.52 | 0.42 | -79.58 | -85.61 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 23.74 | 23.74 | 30.38 | 22.14 | - | 0.9 |
Cash Income Tax Paid | 4.11 | 2.8 | 1.6 | 1.43 | 3.54 | 0.12 |
Change in Working Capital | -106.95 | -56.9 | -87.28 | -32.4 | -58.95 | 8.12 |